Extendicare (EXE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
12 May, 2026Executive summary
Q1 2026 results reflect strong execution of strategy, with organic growth in Home Healthcare, successful acquisitions including the $570 million CBI Home Health deal, and progress in long-term care redevelopment through joint ventures.
Adjusted EBITDA excluding out-of-period items rose 52.2% year-over-year to $44.2 million, with reported Adjusted EBITDA at $52.9 million, and net earnings surged 171% to $40.7 million.
Revenue increased 24.2% year-over-year to $465.2 million, driven by 32.7% Home Healthcare volume growth and acquisitions.
Issued $450 million in senior unsecured notes at 4.345% (five-year term), achieving BBB rating and enhancing capital flexibility.
Integration of recent acquisitions and continued focus on high-quality care and efficiency are key priorities for the remainder of the year.
Financial highlights
Consolidated Q1 revenue rose 24.2% year-over-year to $465.2 million, with Home Healthcare revenue up 29.8% to $205.4 million and long-term care revenue up 23.2% to $243.5 million.
Excluding out-of-period items, Q1 NOI increased by $16.7 million or 38.3%, and adjusted EBITDA rose by $15.2 million or 52%.
Q1 AFFO improved by 65% to $32.7 million; AFFO per share was $0.276, up 56% year-over-year.
Payout ratio declined to 41% on a trailing 12-month basis.
Net earnings per basic share rose to $0.427, and monthly dividend increased by 5% to $0.0441 per share.
Outlook and guidance
Expect organic Home Healthcare growth to moderate but remain above long-term trends due to demographic demand and hospital pressures.
Two new long-term care homes scheduled to open in 2026, with a pipeline of 17 projects representing over 3,700 beds.
Focus for the next few quarters will be on integration of acquisitions, deleveraging, and continued investment in technology and efficiency gains.
Redevelopment funded through capital-efficient joint ventures, with ongoing portfolio upgrades and management fee growth.
Management highlights operating leverage from technology-enabled back office and expects further value creation.
Latest events from Extendicare
- Financial growth, expanded care, and all proposals approved amid sector and integration challenges.EXE
AGM 202626 Apr 2026 - Strong 2025 growth, 5% dividend hike, and $570M CBI Home Health acquisition set for Q2 2026.EXE
Q4 20256 Apr 2026 - Adjusted EBITDA up 42.7% year-over-year, driven by home health care and managed services growth.EXE
Q1 202531 Mar 2026 - Q2 2024 delivered strong revenue, margin growth, and robust progress in redevelopment.EXE
Q2 20241 Feb 2026 - Double-digit revenue and margin growth, with enhanced liquidity and redevelopment progress.EXE
Q3 202414 Jan 2026 - Q4 2024 saw strong growth, margin gains, and a 5% dividend hike amid robust demand.EXE
Q4 20241 Dec 2025 - All proposals passed, with a 5% dividend hike and major growth and governance initiatives.EXE
AGM 202526 Nov 2025 - Q2 2025 delivered 15.4% EBITDA growth and expansion from major acquisitions and home health care.EXE
Q2 202523 Nov 2025 - $570M deal creates Canada’s largest home health care platform, driving growth and efficiency.EXE
M&A Announcement20 Nov 2025